Related News
Home » Metro » Health and Science
New bio agent found to starve liver cancer
LOCAL scientists have developed a new technology to restrain the growth and spread of cancer cells. Pre-clinical tests have found their new biological agent effective on cancer, especially on liver cancer, officials from the Shanghai Institute for Biological Sciences under the Chinese Academy of Sciences said today.
Scientists found they can starve cancer cells by blocking blood vessel growth and interfere the fusion of two target proteins in liver cancer cells.
"We discovered the mechanism and have got a patent in China and some major western countries," said Wu Jiarui, the institute deputy director.
The institute has transferred the patent to pharmaceutical giant, Sanofi-Aventis, for new drug development.
"It should take about 10 years for clinical tests and new drug approval. So far there is only one liver cancer drug in the world and it can only prolong the life of liver cancer patients by normally three months," said Frank Jiang from Sanofi-Aventis.
Scientists found they can starve cancer cells by blocking blood vessel growth and interfere the fusion of two target proteins in liver cancer cells.
"We discovered the mechanism and have got a patent in China and some major western countries," said Wu Jiarui, the institute deputy director.
The institute has transferred the patent to pharmaceutical giant, Sanofi-Aventis, for new drug development.
"It should take about 10 years for clinical tests and new drug approval. So far there is only one liver cancer drug in the world and it can only prolong the life of liver cancer patients by normally three months," said Frank Jiang from Sanofi-Aventis.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.